We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 4,224 results
  1. In HIV-Infected Immunological Non-Responders, Hepatitis C Virus Eradication Contributes to Incomplete Normalization of Systemic Inflammation Indexes, but Does Not Lead to Rapid CD4+ T-Cell Count Recovery

    Abstract

    In HIV-positive individuals taking antiretroviral therapy, coinfection with hepatitis C virus (HCV) increases systemic inflammation, which...

    E. V. Saidakova, L. B. Korolevskaya, ... K. V. Shmagel in Doklady Biochemistry and Biophysics
    Article 01 October 2023
  2. Analyzing energetics and dynamics of hepatitis C virus polymerase interactions with marine bacterial compounds: a computational study

    Hepatitis C Virus (HCV) is a significant health concern affecting a large portion of the global population and is a major cause of acute liver...

    Ahmed Alobaida, Amr S. Abouzied, ... Bader Huwaimel in Molecular Diversity
    Article 10 June 2024
  3. IL28A protein homotetramer structure is required for autolysosomal degradation of HCV-NS5A in vitro

    Interferon lambda-2 (IL28A) has a wide antiviral effect with fewer side-effects. Autophagy is a host mechanism to maintain intracellular homeostasis...

    Yuan-yuan Ma, Jian-rui Li, ... **g-pu Zhang in Cell Death & Disease
    Article Open access 23 March 2020
  4. HCV genotypes and their determinative role in hepatitis C treatment

    Nowadays, exposure to infectious diseases caused by pathogenic viruses has become one of the major human concerns in health fields. In the meantime,...

    Masoud Keikha, Majid Eslami, ... Mohsen Karbalaei in VirusDisease
    Article 04 May 2020
  5. Hepatitis C-associated Osteosclerosis (HCAO): Long-Term Follow-Up of a New Case Recovered After Antiviral Treatment

    Hepatitis C-associated osteosclerosis (HCAO) is a very rare condition that can be observed in a small number of patients with Hepatitis C Virus (HCV)...

    Gaetano Paride Arcidiacono, Carlo Poci, ... Sandro Giannini in Calcified Tissue International
    Article 17 September 2023
  6. A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor

    IFN-alpha have been reported to suppress hepatitis B virus (HBV) cccDNA via APOBEC3 cytidine deaminase activity through interferon signaling. To...

    Yutaka Furutani, Yoshinori Hirano, ... Tomokazu Matsuura in Cell Death Discovery
    Article Open access 22 December 2023
  7. Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus

    Background

    Patients with chronic hepatitis C virus (HCV) infections differ in their risk for metabolic disorders and chronic kidney disease (CKD). The...

    Jia Liu, Wenqian Qi, ... Jiangbin Wang in Lipids in Health and Disease
    Article Open access 03 July 2023
  8. Designing an HCV diagnostic kit for common genotypes of the virus in Iran based on conserved regions of core, NS3-protease, NS4A/B, and NS5A/B antigens: an in silico approach

    Hepatitis C virus (HCV) is a life-threatening virus that causes liver infection. If it is not detected in an early phase, the virus can lead to...

    Katayoun Mehrpour, Seyed Abbas Mirzaei, ... Younes Ghasemi in Biologia
    Article 10 August 2020
  9. Molecular characterization of plasma virome of hepatocellular carcinoma (HCC) patients

    Hepatocellular carcinoma (HCC) stands as the most common cancer type, arising from various causes, and responsible for a substantial number of...

    Niamat Ullah Khan, Asma Sadiq, ... Gezahign Fentahun Wondmie in AMB Express
    Article Open access 25 April 2024
  10. The seropervelance of infectious hepatitis viruses (HBV, HCV and HEV) among blood donors and their correlation to risk factors in Qena governorate, Upper Egypt

    This study was performed to determine the prevalence of HBV and HCV infection among blood donors and the occurrence of HEV in hepatitis viruses...

    Azza Masoud Abdelbaky Ahmed, Hanan Abdelftah Temerk, ... Serageldeen Sultan in VirusDisease
    Article 05 May 2020
  11. Partial nonstructural 3 region analysis of hepatitis C virus genotype 3a

    Background

    The hepatitis C virus (HCV) is a major cause of illness around the world. HCV genotype 3a is the most prevalent genotype in Thailand....

    Anusorn Kiattanaphon, Yaovaluk Vipsoongnern, ... Anchalee Sistayanarain in Molecular Biology Reports
    Article 24 August 2022
  12. A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer

    According to a paper released and submitted to WHO by IARC scientists, there would be 905,700 new cases of liver cancer diagnosed globally in 2020,...

    Leila Kalantari, Zahra Rostami Ghotbabadi, ... Nikoo Emtiazi in Cell Communication and Signaling
    Article Open access 09 November 2023
  13. Hepatitis B virus (HBV) codon adapts well to the gene expression profile of liver cancer: an evolutionary explanation for HBV’s oncogenic role

    Due to the evolutionary arms race between hosts and viruses, viruses must adapt to host translation systems to rapidly synthesize viral proteins....

    Chunpeng Yu, Jian Li, ... Song Wang in Journal of Microbiology
    Article 17 October 2022
  14. Longitudinal multi-omics analyses of the gut–liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis

    The gut and liver are connected via the portal vein, and this relationship, which includes the gut microbiome, is described as the gut–liver axis....

    Rabab O. Ali, Gabriella M. Quinn, ... Theo Heller in Nature Microbiology
    Article 15 December 2022
  15. Invalid results of quantitative HIV and HCV NAT from living, heart beating and after circulatory death donors

    Victoria Stadler Tasca Ribeiro, Allana Pepes, ... Felipe Francisco Tuon in Cell and Tissue Banking
    Article 25 February 2021
  16. How Histone Deacetylase 3 Controls Hepcidin Expression and Hepatitis C Virus Replication

    Abstract

    The key role of histone deacetylases (HDAC) in the regulation of the cellular response to infection with the hepatitis C virus (HCV) was...

    A. S. Shcherbakova, S. N. Kochetkov, M. V. Kozlov in Molecular Biology
    Article 18 June 2023
  17. High dose of bile acid enables the cellular entry and replication of hepatitis C virus in vitro

    Background

    Natural hosts infected with hepatitis C virus (HCV) have a different bile acid (BA) composition than non-natural hosts uninfected. Our...

    Hong-Jai Lee, Bo-Young Shin, ... Soo-Ki Kim in Molecular & Cellular Toxicology
    Article 28 March 2022
  18. Sex-specific changes in triglyceride profiles in liver cirrhosis and hepatitis C virus infection

    Background

    Hepatitis C virus (HCV) infection is associated with serum lipid abnormalities, which partly normalize following direct-acting antiviral...

    Georg Peschel, Jonathan Grimm, ... Christa Buechler in Lipids in Health and Disease
    Article Open access 24 October 2022
  19. Evaluating Drug Resistant Mutations to HCV NS3 Protease Inhibitors in Iranian Naïve Patients

    Hepatitis C virus (HCV) is an important causative agent of acute and chronic hepatitis. The non-structural protein 3 (NS3) of HCV retains two...

    Tayebeh Hashempour, Behzad Dehghani, ... Mohammad Ali Davarpanah in International Journal of Peptide Research and Therapeutics
    Article 14 November 2019
  20. The roles of different microRNAs in the regulation of cholesterol in viral hepatitis

    Cholesterol plays a significant role in stabilizing lipid or membrane rafts, which are specific cellular membrane structures. Cholesterol is involved...

    Xuan Meng, Yeganeh Eslami, ... Renzon Daniel Cosme Pecho in Cell Communication and Signaling
    Article Open access 14 September 2023
Did you find what you were looking for? Share feedback.